Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Terns Pharmaceuticals (TERN) Ownership Overview
16.35% Insiders
8.96% Mutual Funds
0.41% Other Institutional Investors
8.76% ETFs
65.52% Public Companies and
Individual Investors
The ownership structure of Terns Pharmaceuticals (TERN) stock is a mix of institutional, retail, and individual investors. Approximately 18.13% of the company’s stock is owned by Institutional Investors, 16.35% is owned by Insiders, and 65.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 06, 2025 | Jill M. Quigley Director | xxxxxxxxxxxxx | $35693 |
| Jan 06, 2025 | xxxxxxxxxxxxx | $25587 | |
| Jan 06, 2025 | xxxxxxxxxxxxx | $46498 | |
| Sep 17, 2024 | Hongbo Lu Director | xxxxxxxxxxxxx | $4999995 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $334549 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $736814 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1726330 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $9206626 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,237,329 | Insider | 7.34% | 19,834,706 | |
| 3,921,226 | Insider | 6.30% | 12,469,499 | |
| 3,538,351 | Institution | 4.17% | 11,251,956 | |
| 3,162,479 | Institution | 3.72% | 10,056,683 | |
| 3,008,571 | Institution | 3.54% | 9,567,256 | |
| 1,661,846 | Institution | 1.96% | 5,284,670 | |
| 1,245,395 | Institution | 1.47% | 3,960,356 | |
| 1,041,712 | Institution | 1.23% | 3,312,644 | |
| 755,635 | Insider | 0.89% | 2,402,919 | |
| 755,635 | Insider | 0.89% | 2,402,919 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,008,571 | Institution | 3.54% | 9,567,256 | |
| 1,245,395 | Institution | 1.47% | 3,960,356 | |
| 1,041,712 | Institution | 1.23% | 3,312,644 | |
| 666,876 | Institution | 0.79% | 2,120,666 | |
| 454,795 | Institution | 0.54% | 1,446,248 | |
| 446,205 | Institution | 0.53% | 1,418,932 | |
| 441,906 | Institution | 0.52% | 1,405,261 | |
| 313,835 | Institution | 0.37% | 997,995 | |
| 166,541 | Institution | 0.20% | 529,600 | |
| 154,714 | Institution | 0.18% | 491,991 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,072,036 | Institution | 2.44% | 7,645,813 | |
| 1,901,118 | Institution | 2.24% | 6,045,555 | |
| 936,968 | Institution | 1.10% | 3,457,412 | |
| 597,781 | Institution | 0.70% | 1,900,944 | |
| 378,608 | Institution | 0.45% | 1,203,973 | |
| 319,494 | Institution | 0.38% | 1,178,933 | |
| 225,053 | Institution | 0.26% | 776,433 | |
| 172,705 | Institution | 0.20% | 595,832 | |
| 161,151 | Institution | 0.19% | 594,647 | |
| 157,389 | Institution | 0.19% | 500,497 |
FAQ
Who Owns Terns Pharmaceuticals (TERN)?
According to the latest TipRanks data, approximately 0.41% of the company's stock is held by institutional investors, 16.35% is held by insiders, and 65.52% is held by retail investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.41% of Terns Pharmaceuticals (TERN) stock is held by institutional investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.52% of Terns Pharmaceuticals (TERN) stock is held by retail investors.
Who owns the most shares of Terns Pharmaceuticals (TERN)?
Vivo Opportunity, LLC owns the most shares of Terns Pharmaceuticals (TERN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.